THYREGENE INC Trademark

Trademark Overview


On Friday, July 18, 2025, a trademark application was filed for THYREGENE INC with the United States Patent and Trademark Office. The USPTO has given the THYREGENE INC trademark a serial number of 99290339. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, December 12, 2025. The THYREGENE INC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases
thyregene inc

General Information


Serial Number99290339
Word MarkTHYREGENE INC
Filing DateFriday, July 18, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, December 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 18, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressCulver City, CA 90230

Trademark Events


Event DateEvent Description
Friday, July 18, 2025NEW APPLICATION ENTERED
Friday, July 18, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 18, 2025APPLICATION FILING RECEIPT MAILED
Friday, December 5, 2025ASSIGNED TO EXAMINER
Friday, December 12, 2025NON-FINAL ACTION WRITTEN
Friday, December 12, 2025NON-FINAL ACTION E-MAILED
Friday, December 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED